“Novel genetic mutation associated with hyperphosphatemic familial tumoral calcinosis/hyperostosis-hyperphosphatemia syndrome treated with denosumab: a case report” (2024) Reumatismo, 76(2). doi:10.4081/reumatismo.2024.1687.